Search

Au Mali, l’usage des pesticides sur la culture de coton constitue un réel problème de santé publique et pour l’environnement. Cette étude porte sur les risques potentiels correspondant à la « dangerosité » des matières actives présentes dans les pesticides distribués pour le coton. Nous avons recensé 174 pesticides homologués par le Comité sahélien des pesticides (CSP) destinés à la culture du coton, dont 106 insecticides et fongicides et 68 herbicides. Ils sont formulés à partir de 50 matières actives ; 10 sont interdites en Europe et se retrouvent dans 35 produits homologués (soit 20 % des produits disponibles). Un indice de risque de toxicité (IRT) sur la santé des utilisateurs a été calculé pour chacune des 50 matières actives tenant compte de leurs toxicités aiguë et chronique. Il montre que la pendiméthaline et la bifenthrine ont les IRT les plus élevés respectivement pour les herbicides et les insecticides. Un indicateur de contamination des sols et des eaux de surface et souterraine par ces matières actives a été calculé. Il montre qu’une matière active peut présenter un risque important pour la santé et avoir un fort niveau de toxicité pour l’environnement ou avoir un faible impact sur la santé mais présenter un risque élevé pour l’environnement. Une sensibilisation des différents acteurs sur les risques encourus par les pesticides permettrait de réduire leurs impacts sur la santé humaine et l’environnement.

Abstract A “reverse pharmacology” approach to developing an anti-malarial phytomedicine was designed and implemented in Mali, resulting in a new standardized herbal anti-malarial after six years of research. The first step was to select a remedy for development, through a retrospective treatment-outcome study. The second step was a dose-escalating clinical trial that showed a dose-response phenomenon and helped select the safest and most efficacious dose. The third step was a randomized controlled trial to compare the phytomedicine to the standard first-line treatment. The last step was to identify active compounds which can be used as markers for standardization and quality control. This example of “reverse pharmacology” shows that a standardized phytomedicine can be developed faster and more cheaply than conventional drugs. Even if both approaches are not fully comparable, their efficiency in terms of public health and their complementarity should be thoroughly considered.

Abstract Background Hypoglycaemia is a poor prognostic indicator in severe malaria. Intravenous infusions are rarely feasible in rural areas. The efficacy of sublingual sugar (SLS) was assessed in a pilot randomized controlled trial among hypoglycaemic children with severe malaria in Mali. Methods Of 151 patients with presumed severe malaria, 23 children with blood glucose concentrations < 60 mg/dl (< 3.3 mmol/l) were assigned randomly to receive either intravenous 10% glucose (IVG; n = 9) or sublingual sugar (SLS; n = 14). In SLS, a teaspoon of sugar, moistened with a few drops of water, was gently placed under the tongue every 20 minutes. The child was put in the recovery position. Blood glucose concentration (BGC) was measured every 5–10 minutes for the first hour. All children were treated for malaria with intramuscular artemether. The primary outcome measure was treatment response, defined as reaching a BGC of >= 3.3 mmol/l (60 mg/dl) within 40 minutes after admission. Secondary outcome measures were early treatment response at 20 minutes, relapse (early and late), maximal BGC gain (CGmax), and treatment delay. Results There was no significant difference between the groups in the primary outcome measure. Treatment response occurred in 71% and 67% for SLS and IVG, respectively. Among the responders, relapses occurred in 30% on SLS at 40 minutes and in 17% on IVG at 20 minutes. There was one fatality in each group. Treatment failures in the SLS group were related to children with clenched teeth or swallowing the sugar, whereas in the IVG group, they were due to unavoidable delays in beginning an infusion (median time 17.5 min (range 3–40). Among SLS, the BGC increase was rapid among the nine patients who really kept the sugar sublingually. All but one increased their BGC by 10 minutes with a mean gain of 44 mg/dl (95%CI: 20.5–63.4). Conclusion Sublingual sugar appears to be a child-friendly, well-tolerated and effective promising method of raising blood glucose in severely ill children. More frequent repeated doses are needed to prevent relapse. Children should be monitored for early swallowing which leads to delayed absorption, and in this case another dose of sugar should be given. Sublingual sugar could be proposed as an immediate "first aid" measure while awaiting intravenous glucose. In many cases it may avert the need for intravenous glucose.